Mersana Therapeutics snaps up $33 mln

Cambridge, Massachusetts-based biotech company Mersana Therapeutics has closed $33 million in Series C financing. Wellington Management Company led the round with participation from other investors that included Cormorant Asset Management, Arrowpoint Partners, Takeda Pharmaceutical Company Limited, New Enterprise Associates and Rock Springs Capital.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!